Loading...

CV CAPSOVISION INC US FDA Inspections 8-K Filing

CPSV

CV

CAPSOVISION INC

(CV)

2025 8-K

Annual Financial Results

Funding Agreement Signed

Development Agreement Update

FDA Submission Update

Financial Results Released

FDA Application Update

Management Change

Management Changes

Management Change

Financial Results Update

Initial Public Offerings

External Links:

On November 10, 2025, CapsoVision, Inc. announced the submission of a 510(k) FDA application for Breakthrough Device Designation aimed at improving pancreatic cancer screening.

AI Assistant

CAPSOVISION INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.